{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:15:42Z","timestamp":1784650542455,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Parkinson\u2019s disease (PD) is a heterogeneous neurodegenerative disorder with a wide range of clinical phenotypes. Pathologically, it is characterized by neuronal inclusions containing misfolded, fibrillar alpha-synuclein (aSyn). Prion-like properties of aSyn contribute to the spread of aSyn pathology throughout the nervous system as the disease progresses. Utilizing these properties, seed amplification assays (SAA) enable the detection of aSyn pathology in living patients. We hypothesized that structurally distinct aSyn aggregates, or strains, may underlie the clinical heterogeneity of PD. To test this hypothesis, we recursively amplified aSyn fibrils from the cerebrospinal fluid (CSF) of 54 patients (34 people with PD and 20 controls). These fibrils were then characterized regarding SAA kinetic properties and detergent resistance. In addition, cultured cells were transfected with SAA products, and the extent of seeded aSyn pathology was quantified by staining for phosphorylated aSyn followed by automated high-throughput microscopy and image analysis. We found that fibrils, amplified from CSF by recursive SAA, exhibit two types of distinct biophysical properties and have different seeding capacities in cells. These properties are associated with clinical parameters and may therefore help explain the clinical heterogeneity in PD. Measuring aSyn strains may be relevant for prognosis and for therapies targeting aSyn pathology.<\/jats:p>","DOI":"10.1186\/s40478-024-01923-8","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:53:31Z","timestamp":1737399211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recursive seed amplification detects distinct \u03b1-synuclein strains in cerebrospinal fluid of patients with Parkinson\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Stefan","family":"Br\u00e4uer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Schniewind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Dinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn H.","family":"Falkenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"1923_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/mds.20897","volume":"21","author":"G Alves","year":"2006","unstructured":"Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006) Changes in motor subtype and risk for incident dementia in Parkinson\u2019s disease. Mov Disord 21:1123\u20131130. https:\/\/doi.org\/10.1002\/mds.20897","journal-title":"Mov Disord"},{"key":"1923_CR2","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of Ser-129 is the Dominant pathological modification of \u03b1-Synuclein in familial and sporadic Lewy Body Disease *. J Biol Chem 281:29739\u201329752. https:\/\/doi.org\/10.1074\/jbc.M600933200","journal-title":"J Biol Chem"},{"key":"1923_CR3","doi-asserted-by":"publisher","first-page":"a024349","DOI":"10.1101\/cshperspect.a024349","volume":"6","author":"JC Bartz","year":"2016","unstructured":"Bartz JC (2016) Prion strain diversity. Cold Spring Harb Perspect Med 6:a024349. https:\/\/doi.org\/10.1101\/cshperspect.a024349","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1923_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-023-00613-8","volume":"18","author":"G Bellomo","year":"2023","unstructured":"Bellomo G, Paciotti S, Concha-Marambio L, Rizzo D, Wojda\u019aa AL, Chiasserini D, Gatticchi L, Cerofolini L, Giuntini S, De Luca CMG, Ma Y, Farris CM, Pieraccini G, Bologna S, Filidei M, Ravera E, Lelli M, Moda F, Fragai M, Parnetti L, Luchinat C (2023) Cerebrospinal fluid lipoproteins inhibit \u03b1-synuclein aggregation by interacting with oligomeric species in seed amplification assays. Mol Neurodegener 18:20. https:\/\/doi.org\/10.1186\/s13024-023-00613-8","journal-title":"Mol Neurodegener"},{"key":"1923_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D, Borghammer P, Fereshtehnejad S-M, Heinzel S, Horsager J, Schaeffer E, Postuma RB (2021) Prodromal Parkinson disease subtypes \u2014 key to understanding heterogeneity. Nat Rev Neurol 17:349\u2013361. https:\/\/doi.org\/10.1038\/s41582-021-00486-9","journal-title":"Nat Rev Neurol"},{"key":"1923_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P (2021) The \u03b1-Synuclein origin and Connectome Model (SOC Model) of Parkinson\u2019s disease: explaining Motor Asymmetry, Non-motor Phenotypes, and Cognitive decline. J Parkinsons Dis 11:455\u2013474. https:\/\/doi.org\/10.3233\/JPD-202481","journal-title":"J Parkinsons Dis"},{"key":"1923_CR7","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, B\u00f6ckmann A, Meier BH, Melki R (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575. https:\/\/doi.org\/10.1038\/ncomms3575","journal-title":"Nat Commun"},{"key":"1923_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-023-01653-3","volume":"11","author":"S Br\u00e4uer","year":"2023","unstructured":"Br\u00e4uer S, Rossi M, Sajapin J, Henle T, Gasser T, Parchi P, Brockmann K, Falkenburger BH (2023) Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathol Commun 11:162. https:\/\/doi.org\/10.1186\/s40478-023-01653-3","journal-title":"Acta Neuropathol Commun"},{"key":"1923_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40478-021-01276-6","volume":"9","author":"K Brockmann","year":"2021","unstructured":"Brockmann K, Quadalti C, Lerche S, Rossi M, Wurster I, Baiardi S, Roeben B, Mammana A, Zimmermann M, Hauser A-K, Deuschle C, Schulte C, Waniek K, Lachmann I, Sj\u00f6din S, Brinkmalm A, Blennow K, Zetterberg H, Gasser T, Parchi P (2021) Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol Commun 9:175. https:\/\/doi.org\/10.1186\/s40478-021-01276-6","journal-title":"Acta Neuropathol Commun"},{"key":"1923_CR10","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.1315346111","volume":"111","author":"AK Buell","year":"2014","unstructured":"Buell AK, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles TPJ, Linse S, Dobson CM (2014) Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation. Proc Natl Acad Sci U S A 111:7671\u20137676. https:\/\/doi.org\/10.1073\/pnas.1315346111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1923_CR11","doi-asserted-by":"publisher","first-page":"103751","DOI":"10.1016\/j.mcn.2022.103751","volume":"121","author":"M Dehestani","year":"2022","unstructured":"Dehestani M, Liu H, Sreelatha AAK, Schulte C, Bansal V, Gasser T (2022) Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson\u2019s disease. Mol Cell Neurosci 121:103751. https:\/\/doi.org\/10.1016\/j.mcn.2022.103751","journal-title":"Mol Cell Neurosci"},{"key":"1923_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MTM, Parkkinen L, Green AJE (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"key":"1923_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"S-M Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad S-M, Romenets SR, Anang JBM, Latreille V, Gagnon J-F, Postuma RB (2015) New Clinical subtypes of Parkinson Disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863\u2013873. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0703","journal-title":"JAMA Neurol"},{"key":"1923_CR14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/2161310a0","volume":"216","author":"H Fraser","year":"1967","unstructured":"Fraser H, Dickinson AG (1967) Distribution of experimentally Induced Scrapie lesions in the brain. Nature 216:1310\u20131311. https:\/\/doi.org\/10.1038\/2161310a0","journal-title":"Nature"},{"key":"1923_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"1923_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun 6:7. https:\/\/doi.org\/10.1186\/s40478-018-0508-2","journal-title":"Acta Neuropathol Commun"},{"key":"1923_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VMY (2013) Distinct \u03b1-Synuclein strains differentially promote tau inclusions in neurons. Cell 154:103\u2013117. https:\/\/doi.org\/10.1016\/j.cell.2013.05.057","journal-title":"Cell"},{"key":"1923_CR18","doi-asserted-by":"crossref","unstructured":"H\u00e4hnel T, Raschka T, Sapienza S, Klucken J, Glaab E, Corvol J-C, Falkenburger B, Fr\u00f6hlich H (2023) Progression Subtypes in Parkinson\u2019s Disease: A Data-driven Multi-Cohort Analysis. 2023.10.12.23296943","DOI":"10.1101\/2023.10.12.23296943"},{"key":"1923_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"1923_CR20","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK, Geday J, Otto M, Sommerauer M, Danielsen EH, Bech E, Kraft J, Munk OL, Hansen SD, Pavese N, G\u00f6der R, Brooks DJ, Berg D, Borghammer P (2020) Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143:3077\u20133088. https:\/\/doi.org\/10.1093\/brain\/awaa238","journal-title":"Brain"},{"key":"1923_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/chemse\/22.1.39","volume":"22","author":"T Hummel","year":"1997","unstructured":"Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) Sniffin sticks\u2019: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39\u201352. https:\/\/doi.org\/10.1093\/chemse\/22.1.39","journal-title":"Chem Senses"},{"key":"1923_CR22","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/wnl.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 54:1916\u20131921. https:\/\/doi.org\/10.1212\/wnl.54.10.1916","journal-title":"Neurology"},{"key":"1923_CR23","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/wnl.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I (1990) Variable expression of Parkinson\u2019s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529\u20131534. https:\/\/doi.org\/10.1212\/wnl.40.10.1529","journal-title":"Neurology"},{"key":"1923_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41531-023-00466-4","volume":"9","author":"ME Johansson","year":"2023","unstructured":"Johansson ME, van Lier NM, Kessels RPC, Bloem BR, Helmich RC (2023) Two-year clinical progression in focal and diffuse subtypes of Parkinson\u2019s disease. NPJ Parkinsons Dis 9:29. https:\/\/doi.org\/10.1038\/s41531-023-00466-4","journal-title":"NPJ Parkinsons Dis"},{"key":"1923_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T, SPARK Investigators (2022) Trial of Cinpanemab in Early Parkinson\u2019s Disease. N Engl J Med 387:408\u2013420. https:\/\/doi.org\/10.1056\/NEJMoa2203395","journal-title":"N Engl J Med"},{"key":"1923_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC, Stuart E, Menon S, Visanji NP, Meisl G, Faidi R, Marano MM, Schmitt-Ulms C, Wang Z, Fraser PE, Tandon A, Hyman BT, Wille H, Ingelsson M, Klenerman D, Watts JC (2020) \u03b1-Synuclein strains target distinct brain regions and cell types. Nat Neurosci 23:21\u201331. https:\/\/doi.org\/10.1038\/s41593-019-0541-x","journal-title":"Nat Neurosci"},{"key":"1923_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, R\u00f6ytt\u00e4 M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol 100:285\u2013290. https:\/\/doi.org\/10.1007\/s004019900168","journal-title":"Acta Neuropathol"},{"key":"1923_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire LI, Peden AH, Orr\u00fa CD, Wilham JM, Appleford NE, Mallinson G, Andrews M, Head MW, Caughey B, Will RG, Knight RSG, Green AJE (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt\u2013Jakob disease. Ann Neurol 72:278\u2013285. https:\/\/doi.org\/10.1002\/ana.23589","journal-title":"Ann Neurol"},{"key":"1923_CR29","doi-asserted-by":"publisher","unstructured":"Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno S, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, Li Y, Funayama M, Saiki S, Taniguchi D, Tsunemi T, McIntyre D, G\u00e9rardy J-J, Mittelbronn M, Kruger R, Uchiyama Y, Nukina N, Hattori N (2023) Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 1\u20138. https:\/\/doi.org\/10.1038\/s41591-023-02358-9","DOI":"10.1038\/s41591-023-02358-9"},{"key":"1923_CR30","doi-asserted-by":"publisher","first-page":"e1004983","DOI":"10.1371\/journal.ppat.1004983","volume":"11","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa CD, Groveman BR, Raymond LD, Hughson AG, Nonno R, Zou W, Ghetti B, Gambetti P, Caughey B (2015) Bank Vole prion protein as an apparently universal substrate for RT-QuIC-Based detection and discrimination of prion strains. PLoS Pathog 11:e1004983. https:\/\/doi.org\/10.1371\/journal.ppat.1004983","journal-title":"PLoS Pathog"},{"key":"1923_CR31","doi-asserted-by":"publisher","unstructured":"Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay J-P, Mollenhauer B, L\u00f3pez-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D\u2019Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga \u0160, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A, Investigators PASADENA (2022) Prasinezumab Study Group Trial of Prasinezumab in Early-Stage Parkinson\u2019s Disease. N Engl J Med 387:421\u2013432. https:\/\/doi.org\/10.1056\/NEJMoa2202867","DOI":"10.1056\/NEJMoa2202867"},{"key":"1923_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Brockmann K, Svoboda H, Trundell D, Monnet A, Doody R, Fontoura P, Kerchner GA, Brundin P, Nikolcheva T, Bonni A (2024) Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease. Nat Med 30:1096\u20131103. https:\/\/doi.org\/10.1038\/s41591-024-02886-y","journal-title":"Nat Med"},{"key":"1923_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/acschemneuro.9b00594","volume":"11","author":"A Peduzzo","year":"2020","unstructured":"Peduzzo A, Linse S, Buell AK (2020) The properties of \u03b1-Synuclein secondary nuclei are dominated by the solution conditions rather than the seed Fibril strain. ACS Chem Neurosci 11:909\u2013918. https:\/\/doi.org\/10.1021\/acschemneuro.9b00594","journal-title":"ACS Chem Neurosci"},{"key":"1923_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344. https:\/\/doi.org\/10.1038\/nature14547","journal-title":"Nature"},{"key":"1923_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15:14\u201320. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02056.x","journal-title":"Eur J Neurol"},{"key":"1923_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, Froula J, Duffy MF, Lee VMY, Martinez TN, Dave KD (2018) Best practices for Generating and using alpha-synuclein pre-formed fibrils to Model Parkinson\u2019s disease in rodents. J Parkinsons Dis 8:303\u2013322. https:\/\/doi.org\/10.3233\/JPD-171248","journal-title":"J Parkinsons Dis"},{"key":"1923_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.25037","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Arnulf I, Hogl B, Iranzo A, Miyamoto T, Dauvilliers Y, Oertel W, Ju Y-E, Puligheddu M, Jennum P, Pelletier A, Wolfson C, Leu-Semenescu S, Frauscher B, Miyamoto M, De Cock VC, Unger MM, Stiasny-Kolster K, Fantini ML, Montplaisir JY (2012) A single-question screen for REM sleep behavior disorder: a Multicenter Validation Study. Mov Disord 27:913\u2013916. https:\/\/doi.org\/10.1002\/mds.25037","journal-title":"Mov Disord"},{"key":"1923_CR38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"1923_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"W Qiang","year":"2017","unstructured":"Qiang W, Yau W-M, Lu J-X, Collinge J, Tycko R (2017) Structural variation in amyloid-\u03b2 fibrils from Alzheimer\u2019s disease clinical subtypes. Nature 541:217\u2013221. https:\/\/doi.org\/10.1038\/nature20814","journal-title":"Nature"},{"key":"1923_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD, Antelmi E, Mammana A, Hughson AG, Calandra-Buonaura G, Ladogana A, Plazzi G, Cortelli P, Caughey B, Parchi P (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"key":"1923_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, Tsai A-L, Shirani H, Nilsson KPR, Low PA, Soto C (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"key":"1923_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"key":"1923_CR43","doi-asserted-by":"crossref","unstructured":"Singh V, Castellana-Cruz M, Cremades N, Volpicelli-Daley L (2020) Generation and Sonication of \u03b1-synuclein Fibrils","DOI":"10.17504\/protocols.io.bhhrj356"},{"key":"1923_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"1923_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov Disord 28:668\u2013670. https:\/\/doi.org\/10.1002\/mds.25383","journal-title":"Mov Disord"},{"key":"1923_CR46","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K, Mayer G, Sch\u00e4fer S, M\u00f6ller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire\u2013a new diagnostic instrument. Mov Disord 22:2386\u20132393. https:\/\/doi.org\/10.1002\/mds.21740","journal-title":"Mov Disord"},{"key":"1923_CR47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.sleep.2014.08.014","volume":"16","author":"K Stiasny-Kolster","year":"2015","unstructured":"Stiasny-Kolster K, Sixel-D\u00f6ring F, Trenkwalder C, Heinzel-Gutenbrunner M, Seppi K, Poewe W, H\u00f6gl B, Frauscher B (2015) Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson\u2019s disease. Sleep Med 16:186\u2013189. https:\/\/doi.org\/10.1016\/j.sleep.2014.08.014","journal-title":"Sleep Med"},{"key":"1923_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A (2021) CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics 22:433. https:\/\/doi.org\/10.1186\/s12859-021-04344-9","journal-title":"BMC Bioinformatics"},{"key":"1923_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.celrep.2019.06.009","volume":"28","author":"\u00c9M Szeg\u0151","year":"2019","unstructured":"Szeg\u0151 \u00c9M, Dominguez-Meijide A, Gerhardt E, K\u00f6nig A, Koss DJ, Li W, Pinho R, Fahlbusch C, Johnson M, Santos P, Villar-Piqu\u00e9 A, Thom T, Rizzoli S, Schmitz M, Li J, Zerr I, Attems J, Jahn O, Outeiro TF (2019) Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in Synucleinopathies. Cell Rep 28:65\u201377e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.06.009","journal-title":"Cell Rep"},{"key":"1923_CR50","doi-asserted-by":"publisher","first-page":"8621","DOI":"10.1523\/JNEUROSCI.0359-09.2009","volume":"29","author":"W Tang","year":"2009","unstructured":"Tang W, Ehrlich I, Wolff SBE, Michalski A-M, W\u00f6lfl S, Hasan MT, L\u00fcthi A, Sprengel R (2009) Faithful expression of multiple proteins via 2A-peptide self- processing: a versatile and reliable method for manipulating brain circuits. J Neurosci 29:8621\u20138629. https:\/\/doi.org\/10.1523\/JNEUROSCI.0359-09.2009","journal-title":"J Neurosci"},{"key":"1923_CR51","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1038\/s41467-021-23682-z","volume":"12","author":"B Tanudjojo","year":"2021","unstructured":"Tanudjojo B, Shaikh SS, Fenyi A, Bousset L, Agarwal D, Marsh J, Zois C, Heman-Ackah S, Fischer R, Sims D, Melki R, Tofaris GK (2021) Phenotypic manifestation of \u03b1-synuclein strains derived from Parkinson\u2019s disease and multiple system atrophy in human dopaminergic neurons. Nat Commun 12:3817. https:\/\/doi.org\/10.1038\/s41467-021-23682-z","journal-title":"Nat Commun"},{"key":"1923_CR52","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W, Van den Haute C, Gentleman S, Melki R, Baekelandt V (2020) The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol 139:977\u20131000. https:\/\/doi.org\/10.1007\/s00401-020-02157-3","journal-title":"Acta Neuropathol"},{"key":"1923_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2021.05.016","volume":"88","author":"R von Coelln","year":"2021","unstructured":"von Coelln R, Gruber-Baldini AL, Reich SG, Armstrong MJ, Savitt JM, Shulman LM (2021) The inconsistency and instability of Parkinson\u2019s disease motor subtypes. Parkinsonism Relat Disord 88:13\u201318. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.016","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01923-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01923-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:53:36Z","timestamp":1737399216000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01923-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01923-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the local ethics committee (BO-EK-444092021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}